Login to Your Account



Continued 'Overzealousness' at the FDA

Approval Letter on Ceftobiprole Sends Basilea Shares Plunging

By Cormac Sheridan and Jennifer Boggs


Wednesday, March 19, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription